Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma ; day:19 ; month:6 ; year:2024 ; pages:1-8
European journal of nuclear medicine and molecular imaging ; (19.6.2024), 1-8
- Urheber
-
Schloetelburg, Wiebke
Hartrampf, Philipp E.
Kosmala, Aleksander
Serfling, Sebastian E.
Dreher, Niklas
Schirbel, Andreas
Faßnacht, Martin
Buck, Andreas K.
Werner, Rudolf A.
Hahner, Stefanie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-024-06800-z
- URN
-
urn:nbn:de:101:1-2409102118304.903841663700
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
30.08.2024, 08:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schloetelburg, Wiebke
- Hartrampf, Philipp E.
- Kosmala, Aleksander
- Serfling, Sebastian E.
- Dreher, Niklas
- Schirbel, Andreas
- Faßnacht, Martin
- Buck, Andreas K.
- Werner, Rudolf A.
- Hahner, Stefanie
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma](/assets/placeholder/searchResultMediaUnknown.png)
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
The role of molecular profiling in adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
The role of molecular profiling in adrenocortical carcinoma
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma
Radiopharmaceuticals for treatment of adrenocortical carcinoma
Kyriotop - "Personale Formation von Religion" bei Paulus
CXCR4-targeted theranostics in oncology
CXCR4-targeted theranostics in oncology
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients
Novel CYP11B-ligand [\(^123/131}\)I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography